Skip to main content
Annals of Surgery logoLink to Annals of Surgery
. 1987 May;205(5):563–571. doi: 10.1097/00000658-198705000-00016

Early results with combined modality therapy for carcinoma of the esophagus.

W G Wolfe, G V Burton, H F Seigler, I R Crocker, A L Vaughn
PMCID: PMC1493010  PMID: 3579403

Abstract

Since January 1984, 74 patients (61 men, 13 women; age range: 43-76 years) with carcinoma of the esophagus were evaluated. Fifty-two patients had squamous cell carcinoma and 22 patients had adenocarcinoma. Sixty-three patients had preoperative chemotherapy and radiation that consisted of cis-platinum and VP-16 for squamous cell carcinoma and cis-platinum 5-FU for adenocarcinoma combined with 4500-6000 rads. Thirty-four patients were staged inoperable at the completion of the 4-month treatment regimen. Eleven patients had surgery alone because they refused or were not candidates for the preoperative regimen. Twenty-nine patients completed the combined modality regimen and have had esophagogastrostomy. All patients receiving chemotherapy and radiation demonstrated improved swallowing and a dramatic reduction of tumor mass early in the course of therapy and have been able to maintain oral nutrition without other support in the posttreatment period. Of the 34 patients who had chemotherapy and radiation therapy as palliation, 18 are currently living. One patient died secondary to complications of chemotherapy, another patient died at 9 months of myocardial infarction. The remaining patients died secondary to their disease. Of the 29 patients who had radiation therapy and chemotherapy plus esophagogastrostomy, 25 are alive. There were no operative deaths. One patient died at 9 months of stroke. Three other patients had recurrence and died 1 year after surgery. Of the 11 patients who had surgery alone, two have died of the disease. Of the 29 patients who completed the integrated therapy, 10 had no evidence of residual tumor in the specimen, and in an additional five patients only microscopic foci were evident. These early results are an encouragement to continue the multidiscipline approach to carcinoma of the esophagus in the hope that the quality of life and disease-free interval, as well as ultimate survival, will be enhanced.

Full text

PDF
565

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Goldfaden D., Orringer M. B., Appelman H. D., Kalish R. Adenocarcinoma of the distal esophagus and gastric cardia. Comparison of results of transhiatal esophagectomy and thoracoabdominal esophagogastrectomy. J Thorac Cardiovasc Surg. 1986 Feb;91(2):242–247. [PubMed] [Google Scholar]
  2. Kelsen D., Hilaris B., Coonley C., Chapman R., Lesser M., Dukeman M., Heelan R., Bains M. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. Am J Med. 1983 Oct;75(4):645–652. doi: 10.1016/0002-9343(83)90451-5. [DOI] [PubMed] [Google Scholar]
  3. Leichman L., Steiger Z., Seydel H. G., Dindogru A., Kinzie J., Toben S., MacKenzie G., Shell J. Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach. J Clin Oncol. 1984 Feb;2(2):75–79. doi: 10.1200/JCO.1984.2.2.75. [DOI] [PubMed] [Google Scholar]
  4. Miller J. I., McIntyre B., Hatcher C. R., Jr Combined treatment approach in surgical management of carcinoma of the esophagus: a preliminary report. Ann Thorac Surg. 1985 Sep;40(3):289–293. doi: 10.1016/s0003-4975(10)60044-6. [DOI] [PubMed] [Google Scholar]
  5. Nakayama K., Kinoshita Y. Cancer of the gastrointestinal tract. II. Esophagus: Treatment--localized and advanced. Surgical treatment combined with preoperative concentrated irradiation. JAMA. 1974 Jan 14;227(2):178–181. doi: 10.1001/jama.227.2.178. [DOI] [PubMed] [Google Scholar]
  6. Orringer M. B. Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg. 1984 Sep;200(3):282–288. doi: 10.1097/00000658-198409000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Popp M. B., Hawley D., Reising J., Bongiovanni G., Weesner R., Moomaw C. J., Martelo O., Aron B. Improved survival in squamous esophageal cancer. Preoperative chemotherapy and irradiation. Arch Surg. 1986 Nov;121(11):1330–1335. doi: 10.1001/archsurg.121.11.1330. [DOI] [PubMed] [Google Scholar]
  8. Shahian D. M., Neptune W. B., Ellis F. H., Jr, Watkins E., Jr Transthoracic versus extrathoracic esophagectomy: mortality, morbidity, and long-term survival. Ann Thorac Surg. 1986 Mar;41(3):237–246. doi: 10.1016/s0003-4975(10)62762-2. [DOI] [PubMed] [Google Scholar]
  9. Shields T. W., Rosen S. T., Hellerstein S. M., Tsang T., Ujiki G. T., Kies M. S. Multimodality approach to treatment of carcinoma of the esophagus. Arch Surg. 1984 May;119(5):558–562. doi: 10.1001/archsurg.1984.01390170054011. [DOI] [PubMed] [Google Scholar]
  10. Skinner D. B. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg. 1983 Jan;85(1):59–71. [PubMed] [Google Scholar]
  11. Skinner D. B., Little A. G., Ferguson M. K., Soriano A., Staszak V. M. Selection of operation for esophageal cancer based on staging. Ann Surg. 1986 Oct;204(4):391–401. doi: 10.1097/00000658-198610000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Steiger Z., Franklin R., Wilson R. F., Leichman L., Seydel H., Loh J. J., Vaishamapayan G., Knechtges T., Asfaw I., Dindogru A. Eradication and palliation of squamous cell carcinoma of the esophagus with chemotherapy, radiotherapy, and surgical therapy. J Thorac Cardiovasc Surg. 1981 Nov;82(5):713–719. [PubMed] [Google Scholar]
  13. Sugimachi K., Matsufuji H., Kai H., Masuda H., Ueo H., Inokuchi K., Jingu K. Preoperative irradiation for carcinoma of the esophagus. Surg Gynecol Obstet. 1986 Feb;162(2):174–176. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES